These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39398850)

  • 1. Ninjin'yoeito in the Management of Frailty and Overactive Bladder in Elderly Women: A Report of Two Cases.
    Okui N
    Cureus; 2024 Sep; 16(9):e69304. PubMed ID: 39398850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ninjin'yoeito Improves Genitourinary Symptoms in Patients With Frailty.
    Okui N; Okui MA
    Cureus; 2023 Jun; 15(6):e40767. PubMed ID: 37363115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Practicality of Causal Inference From Non-randomized Observational Data in Small-Scale Clinical Settings: A Study on the Effects of Ninjin'yoeito.
    Okui N
    Cureus; 2024 Mar; 16(3):e55825. PubMed ID: 38463406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty.
    Kashima M
    Front Nutr; 2021; 8():547512. PubMed ID: 33937301
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement in Frailty in a Patient With Severe Chronic Obstructive Pulmonary Disease After Ninjin'yoeito Therapy: A Case Report.
    Kuniaki H; Akihiko T; Tetsuya H; Hatsuko M; Tomoko K; Shin O; Sojiro K; Mayumi Y; Fumihiro Y; Shintaro S; Tsukasa O; Hironori S
    Front Nutr; 2018; 5():71. PubMed ID: 30234120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Ninjin'yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice.
    Amitani H; Chiba S; Amitani M; Michihara S; Takemoto R; Han L; Fujita N; Takahashi R; Inui A
    Front Pharmacol; 2022; 13():973897. PubMed ID: 36353482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
    Konishi S; Hatakeyama S; Imai A; Kumagai M; Okita K; Togashi K; Hamaya T; Hamano I; Okamoto T; Iwamura H; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
    Low Urin Tract Symptoms; 2021 Jan; 13(1):56-63. PubMed ID: 32496639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty.
    Hirai K; Homma T; Matsunaga T; Akimoto K; Yamamoto S; Suganuma H; Kashima A; Sato H; Ebato T; Miyata Y; Ohta S; Inoue H; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    J Altern Complement Med; 2020 Aug; 26(8):750-757. PubMed ID: 32551796
    [No Abstract]   [Full Text] [Related]  

  • 10. Frailty Improvement by Multicomponent Drug, Ninjin'Yoeito, in Mild Cognitive Impairment and Mild Alzheimer's Disease Patients: An Open-Label Exploratory Study (FRAMINGO).
    Okahara K; Ohsawa M; Haruta-Tsukamoto A; Miyoshi R; Funahashi H; Fukutani Y; Makita S; Matsuo H; Ishida Y
    J Alzheimers Dis Rep; 2023; 7(1):107-117. PubMed ID: 36891253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinical Study of Ninjin'yoeito With Regard to Frailty.
    Sakisaka N; Mitani K; Sempuku S; Imai T; Takemoto Y; Shimomura H; Ushiroyama T
    Front Nutr; 2018; 5():73. PubMed ID: 30320119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Effects of Ninjin'yoeito on Physical Frailty in Mice.
    Otsuka S; Fukumaru K; Tani A; Takada S; Kikuchi K; Norimatsu K; Matsuzaki R; Matsuoka T; Sakakima H; Omiya Y; Mizuno K; Matsubara Y; Maruyama I
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study).
    Nakagomi H; Mitsui T; Shimura H; Ihara T; Kira S; Sawada N; Takeda M
    BMC Urol; 2022 Mar; 22(1):40. PubMed ID: 35313873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study.
    Choi H; Bae JH; Oh CY; Jeong SJ; Ko WJ; Choi JB; Seo JT; Lee DH; Kim JC; Lee KW; Kim YH
    Int Neurourol J; 2018 Mar; 22(1):51-57. PubMed ID: 29609421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ninjin'yoeito, a traditional Japanese medicine, attenuates age-related deficits of muscle performance, self-care motivation, and body temperature in C57BL/6 mice.
    Matsubara Y; Miyama Y; Imai R; Oizumi H; Miyazaki S; Haneda E; Mizuno K; Omiya Y; Ikeda Y; Mizoguchi K
    Biosci Biotechnol Biochem; 2022 Jun; 86(7):895-901. PubMed ID: 35396846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good Rehabilitation Outcomes and Improved Nutritional Status After Treatment With the Japanese Herbal Medicine Ninjin'yoeito in an Elderly Patient With Hip Fracture and Sarcopenia: A Case Report.
    Morinaga A; Nakamura H; Hattanmaru K; Rokot NT; Kimura Y; Ito T
    Front Nutr; 2020; 7():85. PubMed ID: 32714940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Possibility of Simultaneous Treatment with the Multicomponent Drug, Ninjin'yoeito, for Anorexia, Apathy, and Cognitive Dysfunction in Frail Alzheimer's Disease Patients: An Open-Label Pilot Study.
    Ohsawa M; Tanaka Y; Ehara Y; Makita S; Onaka K
    J Alzheimers Dis Rep; 2017 Dec; 1(1):229-235. PubMed ID: 30480240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term administration of ninjin'yoeito to treat frailty in older adults: A case series.
    Sakisaka N
    Neuropeptides; 2022 Jun; 93():102244. PubMed ID: 35381491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty.
    Uto NS; Amitani H; Atobe Y; Sameshima Y; Sakaki M; Rokot N; Ataka K; Amitani M; Inui A
    Front Nutr; 2018; 5():126. PubMed ID: 30619872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.